{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:14:56Z","timestamp":1770534896422,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.chest.2020.10.071","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T09:12:47Z","timestamp":1617700367000},"page":"e189-e191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate"],"prefix":"10.1016","volume":"159","author":[{"given":"Satoshi","family":"Tamaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Osada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takane","family":"Kin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Arimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2020.10.071_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.siny.2017.03.005","article-title":"Congenital chylothorax","volume":"22","author":"Attar","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.chest.2020.10.071_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1891\/0730-0832.38.6.357","article-title":"Congenital chylothorax: common and uncommon findings in an infant with chylous effusions","volume":"38","author":"DeWitt","year":"2019","journal-title":"Neonatal Netw"},{"issue":"4","key":"10.1016\/j.chest.2020.10.071_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.2013-2072","article-title":"Chylothorax in infants and children","volume":"133","author":"Tutor","year":"2014","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.chest.2020.10.071_bib4","first-page":"CD006388","article-title":"Octreotide for the treatment of chylothorax in neonates","volume":"8","author":"Das","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.chest.2020.10.071_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/jpc.13889","article-title":"Octreotide for congenital and acquired chylothorax in newborns: a systematic review","volume":"54","author":"Bellini","year":"2018","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"3","key":"10.1016\/j.chest.2020.10.071_bib6","first-page":"91","article-title":"Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited\u2014A multicenter retrospective study","volume":"45","author":"Bellini","year":"2012","journal-title":"Lymphology"},{"issue":"2","key":"10.1016\/j.chest.2020.10.071_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/archdischild-2014-307274","article-title":"Congenital chylothorax: a prospective nationwide epidemiological study in Germany","volume":"100","author":"Bialkowski","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.chest.2020.10.071_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chest.2018.02.005","article-title":"Use of an alpha-1 adrenoreceptor agonist in the management of recurrent refractory idiopathic chylothorax","volume":"154","author":"Sivakumar","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2020.10.071_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.12-3081","article-title":"Midodrine, a novel therapeutic for refractory chylothorax","volume":"144","author":"Liou","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2020.10.071_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1569-9293(03)00263-9","article-title":"Etilefrine use in the management of post-operative chyle leaks in thoracic surgery","volume":"3","author":"Guillem","year":"2004","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"7","key":"10.1016\/j.chest.2020.10.071_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/pd.5066","article-title":"The outcomes and prognostic factors of fetal hydrothorax associated with trisomy 21","volume":"37","author":"Yumoto","year":"2017","journal-title":"Prenat Diagn"}],"updated-by":[{"DOI":"10.1016\/j.chest.2022.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220351308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220351308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:17:23Z","timestamp":1643807843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220351308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0012369220351308"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.10.071","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}